Ocugen (OCGN) Cash from Investing Activities (QoQ) (2014 - 2026)
Ocugen (OCGN) Cash from Investing Activities (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Ocugen | 399.60 Mn | 399.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82.86% |
| Dec 31, 2025 | 59.30% |
| Sep 30, 2025 | 2.27% |
| Jun 30, 2025 | 13.73% |
| Mar 31, 2025 | -684.62% |
| Dec 31, 2024 | 97.44% |
| Sep 30, 2024 | 1.17% |
| Jun 30, 2024 | 78.19% |
| Mar 31, 2024 | 13.59% |
| Dec 31, 2023 | 19.11% |
| Sep 30, 2023 | -158.80% |
| Jun 30, 2023 | 66.32% |
| Mar 31, 2023 | 122.50% |
| Dec 31, 2022 | -18,327.71% |
| Sep 30, 2022 | 93.92% |
| Jun 30, 2022 | -512.56% |
| Mar 31, 2022 | -16.15% |
| Dec 31, 2021 | 45.14% |
| Sep 30, 2021 | 65.45% |
| Jun 30, 2021 | -288.12% |